Cargando…
Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease
Background: Adropin, a peptide translated from the Energy Homeostasis Associated gene (ENHO), was mainly expressed in the liver and was a regulator in metabolic and energy homeostasis. This study aims to investigate the correlation between adropin and histological characteristics of the liver, and t...
Autores principales: | Li, Na, Xie, Guomin, Zhou, Biao, Qu, Aijuan, Meng, Hua, Liu, Jia, Wang, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339918/ https://www.ncbi.nlm.nih.gov/pubmed/34366886 http://dx.doi.org/10.3389/fphys.2021.696163 |
Ejemplares similares
-
Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease
por: Zhang, Lin, et al.
Publicado: (2023) -
Serum adropin as a predictive biomarker of erectile dysfunction in coronary artery disease patients
por: Celik, Hüsetin Tugrul, et al.
Publicado: (2019) -
Serum Adropin Levels in Patients on Hemodialysis
por: Boric-Skaro, Dijana, et al.
Publicado: (2021) -
Comparison of Serum Adropin Levels in Patients with Diabetes Mellitus, COVID-19, and COVID-19 with Diabetes Mellitus
por: Aydın, Pelin, et al.
Publicado: (2022) -
Serum Metabolomic Profiling to Reveal Potential Biomarkers for the Diagnosis of Fatty Liver Hemorrhagic Syndrome in Laying Hens
por: Guo, Lianying, et al.
Publicado: (2021)